GENMAB AS revenue breakdown overview

GENMAB AS revenue for the last year amounted to 41.42 B MXN, the most of which — 41.42 B MXN — came from its highest performing source at the moment, Antibody Therapeutics, the year earlier bringing 40.85 B MXN. The greatest contribution to the revenue figure was made by Denmark — last year it brought GENMAB AS 40.36 B MXN, and the year before that — 40.85 B MXN.